81-year-old Texan hauled lost luggage up to 14 hours a day for wife’s cancer bills. Strangers raised $600K+. Will Medicare leave you exposed?

Traditional Medicare carries no cap on annual out-of-pocket costs, meaning a serious illness like pancreatic cancer can generate bills that grow without limit. Those without supplemental coverage face a $1,736 hospital stay deductible, daily co-payments for extended stays and 20% coinsurance for outpatient services — on top of the standard Part B monthly premium of $203.

Cancer treatment can raise the burden

Pancreatic cancer is among the deadliest, plus one of the most expensive types to treat, according to an analysis published by Indiana University. It found the average direct medical cost per pancreatic cancer patient was $177,691 in 2025 — with estimated total national spending on pancreatic cancer reaching approximately $12 billion annually.

The Medicare cancer treatment coverage booklet notes Medicare covers many cancer-related services under Parts A, B and D — but patients still bear co-pays, coinsurance, deductibles and costs for services Medicare doesn’t cover, which can quickly accumulate into five or six figures annually for aggressive cancers.

What beneficiaries can do

The most direct protection against uncapped costs in traditional Medicare is a Medigap supplemental policy, which covers some or all of Medicare’s cost-sharing requirements.

According to KFF, more than half of Medicare beneficiaries — 54% or 34.1 million people — are enrolled in Medicare Advantage plans, which cap annual out-of-pocket costs, unlike traditional Medicare.

For prescription drug costs specifically, Medicare.gov confirms that Part D out-of-pocket spending is now capped at $2,100 in 2026 — a meaningful protection for high-cost drug regimens, though it covers only prescription drugs, not the broader costs of cancer care.